Cancer Research Audrey Hepburn  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruch, J.
Right arrow Articles by Hameister, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruch, J.
Right arrow Articles by Hameister, H.
[Cancer Research 60, 4526-4530, August 15, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

Delineation of the 6p22 Amplification Unit in Urinary Bladder Carcinoma Cell Lines1

Jochen Bruch, Wolfgang A. Schulz, Jürgen Häussler, Ingo Melzner, Silke Brüderlein, Peter Möller, Ralf Kemmerling, Walther Vogel and Horst Hameister2

Department of Medical Genetics [J. B., J. H., R. K., W. V., H. H.] and Department of Pathology [I. M., S. B., P. M., R. K.], University Ulm, Albert-Einstein-Allee 11, D-89069 Ulm, Germany; and Department of Urology, Heinrich-Heine-University Düsseldorf, Moorenstraße 5, D-40225 Düsseldorf, Germany [W. A. S.]

Eight cell lines from transitional cell carcinoma of the urinary bladder were analyzed by comparative genomic hybridization. All tumor lines exhibited frequent chromosome gains (11.5/cell line) and losses (8.4/cell line). In six cell lines, gain of chromosome 5p was associated with gains of 6p and 20q. In five of these cell lines, amplification of parts of 6p was observed. Cytogenetic investigation combined with fluorescence in situ hybridization analysis revealed typical marker chromosomes with homogeneously staining regions (HSRs) containing material from 6p. By hybridizing individual yeast artificial chromosome probes from a chromosome 6p contig to these HSRs, a contig of three yeast artificial chromosomes common to all 6p HSRs was identified that spans less than 2 Mb. The genes SOX4 and PRL were shown to map to this region and to be coamplified in the cell lines. However, SOX4 was not overexpressed in any cell line and PRL was not expressed at all. Thus, the presumptive 6p oncogene remains to be conclusively identified.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
X.-Y. Lu, Y. Lu, Y.-J. Zhao, K. Jaeweon, J. Kang, L. Xiao-Nan, G. Ge, R. Meyer, L. Perlaky, J. Hicks, et al.
Cell Cycle Regulator Gene CDC5L, a Potential Target for 6p12-p21 Amplicon in Osteosarcoma
Mol. Cancer Res., June 1, 2008; 6(6): 937 - 946.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G. C Santos, M Zielenska, M Prasad, and J A Squire
Chromosome 6p amplification and cancer progression
J. Clin. Pathol., January 1, 2007; 60(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Aaboe, K. Birkenkamp-Demtroder, C. Wiuf, F. B. Sorensen, T. Thykjaer, G. Sauter, K. M.-E. Jensen, L. Dyrskjot, and T. Orntoft
SOX4 Expression in Bladder Carcinoma: Clinical Aspects and In vitro Functional Characterization.
Cancer Res., April 1, 2006; 66(7): 3434 - 3442.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Knowles
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
Carcinogenesis, March 1, 2006; 27(3): 361 - 373.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. J. Evans, B. L. Gallie, M. A.S. Jewett, G. R. Pond, K. Vandezande, J. Underwood, Y. Fradet, G. Lim, P. Marrano, M. Zielenska, et al.
Defining a 0.5-Mb Region of Genomic Gain on Chromosome 6p22 in Bladder Cancer by Quantitative-Multiplex Polymerase Chain Reaction
Am. J. Pathol., January 1, 2004; 164(1): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Harding, K. C. Arden, J. W. Gildea, J. J. Gildea, E. J. Perlman, C. Viars, and D. Theodorescu
Functional Genomic Comparison of Lineage-related Human Bladder Cancer Cell Lines with Differing Tumorigenic and Metastatic Potentials by Spectral Karyotyping, Comparative Genomic Hybridization, and a Novel Method of Positional Expression Profiling
Cancer Res., December 1, 2002; 62(23): 6981 - 6989.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Primdahl, F. P. Wikman, H. von der Maase, X.-g. Zhou, H. Wolf, and T. F. Orntoft
Allelic Imbalances in Human Bladder Cancer: Genome-Wide Detection With High-Density Single-Nucleotide Polymorphism Arrays
J Natl Cancer Inst, February 6, 2002; 94(3): 216 - 223.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Chen, S. Pajovic, A. Duckett, V. D. Brown, J. A. Squire, and B. L. Gallie
Genomic Amplification in Retinoblastoma Narrowed to 0.6 Megabase on Chromosome 6p Containing a Kinesin-like Gene, RBKIN
Cancer Res., February 1, 2002; 62(4): 967 - 971.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.